局部麻醉(英文版)課件_第1頁
局部麻醉(英文版)課件_第2頁
局部麻醉(英文版)課件_第3頁
局部麻醉(英文版)課件_第4頁
局部麻醉(英文版)課件_第5頁
已閱讀5頁，還剩37頁未讀， 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明：本文檔由用戶提供并上傳，收益歸屬內(nèi)容提供方，若內(nèi)容存在侵權(quán)，請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

Anesthesia

Localanesthesia

wangjieUnionHospitalHistoryCocaplantleavesinPeru.Cocainewasisolatedin1860Firstusedasalocalanestheticin1884.Procainein1904.lidocainein1943,Bupivacainein1957andprilocainein1959.DefinitionLocalanesthesiaisanytechniquetorenderpartofthebodyinsensitivetopainwithoutaffectingconsciousness.Alocalanestheticisadrugthatreversiblyinhibitsthepropagationofsignalsalongnerves.Analgesia(lossofpainsensation)Paralysis(lossofmusclepower)LocalAnestheticsPharmacologyClassificationStructureAminoesters:procainetetracaineAminoamides:bupivacainelidocaineropivacaineEffectiveTimeShortterm:procaineMiddle:lidocaineLong：bupivacainetetracaineropivacaine(pKa)=pH-log[B]/[BH+]

OnsetTime

BasesIonicpositiveionPharmacology2.LipidsolubilityItseffectononsetispoorlyunderstoodhighlipidsolubilityincrateofdiffandshortenonsettimeBUTitalsoincsolubilityinthesurroundingtissuePharmacologyPlasmaconcentration:dependsonabsorptionkineticsHOWWHEREsystemicdispositionkineticsDistributionEliminationmetabolism

PlasmaEZLiverEZexcretionPharmacologyPHARMACOKINETICSAbsorptionofLASiteofinjection(intercostal>caudal>brachialplexusetc)Dosage(bloodlevelofLArelatedtototaldoseofdrugratherthanspesificvolumeorconcentrationofsolutionAdditionofvasoconstrictorMetabolismofLAA.ESTERSRapidhydrolysisbyplasmacholinesteraseWatersolublemetabolitesexcretedintheurine(p-aminobenzoic,diethylaminoethanolAbnormalpseudocholinesteraseincriskoftoxicsideeffectCSFlackofesteraseenzymeExceptionCocain-partiallymetabolizedinliverandpartiallyexcretedinurineunchangedCont.B.AMIDEEnzymaticdegradationinliverbymicrosomalenzymes(prilocaine>lidnocaine>mepivacaine>bupivacaineandetidocaine)MuchslowerthanesterhydrolysisN-dealkylation,aromaticandamidehydrolysisDecreasehepaticfunctionorhepaticbloodflowreducemetabolicratepredsystemictoxicityVerylittledrugexcretedunchangedbykidneyMechanismofactionInhibitingsodiuminfluxthroughsodium-specificionchannelsinparticulartheso-calledvoltage-gatedsodiumchannelsactionpotentialcannotariseandsignalconductionisthusinhibitedLocalanesthetics

Sideeffect1.Toxicity2.Hypersensitivity/AllergyUndesiredeffects!!!Toxicity

mayoccurif

ThemaximumsafedoseisexceededTransienthighbloodlevelsareachievedbyaccidentalintravenousinjectionRapidabsorptionfromaninflamedorvascularareaUsenormaldosetoweakpatientsLocalanesthetics

SideeffectCentralnervoussystemExcitatoryorDepressive

Atlowerconcentrations,arelativelyselectivedepressionofinhibitoryneuronsresultsincerebralexcitation,whichmayleadtogeneralizedconvulsions.

Aprofounddepressionofbrainfunctionsoccursathigherconcentrationswhichmayleadtocoma,respiratoryarrestanddeath.CardiovascularsystemBradycardia,buttachyarrhythmiacanalsooccur.Withhighplasmalevelsoflidocainetheremaybehigher-degreeatrioventricularblockandseverebradycardia,leadingtocomaandpossiblydeath.ManagementoftoxicityOxygenation:theairwayismaintainedandoxygenadministeredbyface-mask,usingartificialventilationifapnoeaoccursManagementoftoxicityControlofconvulsions:withsmallincrementsofeitheriazepam(5mg)orthiopentone(50mg).ButexcessivedosesshouldnotbegivensincecardiorespiratorydepressionmaybehappenManagementoftoxicityCirculatorysupport:hypotensionmayneedtobetreatedwithvasopressorsorinotropes(e.G.Ephedrinein10mgincrements).Arrythemiamustbemanagedandifcardiacarresthappened,CPCRshouldbeperformedimmediatelylidocainepKa7.85Plainaqsolution1,1.5,2%@pH5-7Solutionwithadrenalin@pH3-4.5Ralativepotency2T1/2?adult1.8hr,neonate2hrXtremelystableMaxdose:plain3mg/kg,adrenalin7mg/kgE.A.of400mg/70kg@[blood]=2-4ug/mlToxicitybegin@5ug/mlRelativelyquicklyabsorbedfromGITMetabinliver(dealkylation)excretedurineToxicdoseleadtodeathbyVForcardiacarrestSuitableforsurface,infiltration,nerveblock,caudal,epiduralandSABupivacainepKa8.1Plainaqsoln.25,.375,.5%@pH4.5-6IfwithadrenalinpH3.5-5.5Potency8Proteinbinding95%>lipidsolubilitythanlidocaineT1/2?adult3.5hr,neonate8.1-14hrAmidelinkLAProdprolongedanaesthesiawithsloweronsetAddadrenalin-toxicity,h/enochangeindurationPostopanalgesia:IC7hr,EA3-4hrEpid/caudalpeak[plasma]30-45minLowerfoetal/maternalratiocflidnocaine(!Proteinbinding)Maxdose:plain/withadrenalin2mg/kgRopivacaineChemicalanalogueofbupivacaineThemoleculeisdesignedtomodifythespesificcardiotoxicityassociatedwithbupivacainepKa8.2andpHsolution5.5-6.0EquallypotentasbupivacaineItsqualityofclinicalblockappeartobeverysimilarinonset,durationandqualitythatofbupivacaineNospesifictoxicityhasbeendetectedLocalanesthesia

MethodsLocalanesthesiaSurfaceanesthesiaLocalinfiltrationanesthesiaRegionalblockNerveblockPhysiologyCSF：120～150ml(space23～30ml)，pressurelieononeside70～170mmh2o，siteposition200～300mmh2o。

AssociatedwithdistributionoflocalanestheticsEffectSiteSpinalnerverootSpinalanesthesia:DirectaffectEpiduralanesthesia:

(1)InfiltratinginCSF(2)SpinalnerveSequenceofnerveblocksympatheticnerveEstheticnerveMotornerveDifferentialblock

(Ropivacaine)Lowerdosesorconcentrationsmayselectivelyinhibitpainsensationwithminimalaffectonmusclepower.Sometechniquesofpaintherapy,suchaswalkingepiduralsforlaborpainusethiseffect,termeddifferentialblock.SpinalBlockAmoredenseblockFastonsetUsedmoreoftenforC/SCommon

溫馨提示

  • 1. 本站所有資源如無特殊說明，都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等，如果需要附件，請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙，網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽，若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間，僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理，對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯，并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容，請(qǐng)與我們聯(lián)系，我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論